Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bacillus mesentericus
- Development stage
- Unknown
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Bacillus mesentericus is a spore-forming, Gram-positive bacterium commonly found in soil, water, and the gastrointestinal tracts of animals. It is primarily used as a probiotic supplement to promote gastrointestinal health. As a probiotic, Bacillus mesentericus helps restore and maintain the balance of beneficial bacteria in the gut, supports digestion by regulating abnormal bowel movements, and enhances immune function. It may also exhibit antimicrobial properties against certain pathogens. Clinical uses include management of antibiotic-associated diarrhea, infectious diarrhea, gastroenteritis, inflammatory bowel disease (IBD), constipation, Clostridium difficile-associated diarrhea, irritable bowel syndrome (IBS), Helicobacter pylori infection, traveler’s diarrhea, lactose intolerance symptoms relief in some patients with chronic constipation or other GI disturbances[1][4][8]. The mechanism involves inhibition of pathogenic bacterial growth and support for healthy intestinal microflora.
- Other names
- Bacillus mesentericus
Beyond the preview
Go deeper on bacillus mesentericus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bacillus mesentericus.